REGENXBIO, Inc. (RGNX)
8.57
-0.51
(-5.62%)
USD |
NASDAQ |
Mar 13, 16:00
8.56
-0.01
(-0.12%)
After-Hours: 20:00
REGENXBIO EPS Diluted (Quarterly) : -1.298 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -3.934 |
| AbbVie, Inc. | 1.018 |
| Replimune Group, Inc. | -0.7694 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Altimmune, Inc. | -0.2719 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.15M |
| Revenue (Quarterly) | 30.34M |
| Total Expenses (Quarterly) | 97.49M |
| Enterprise Value | 472.77M |
| Gross Profit Margin (Quarterly) | 67.71% |
| Profit Margin (Quarterly) | -221.3% |
| Earnings Yield | -43.81% |
| Normalized Earnings Yield | -43.81 |